Skip to content

Clinical Efficacy Evaluation and Mechanism Research on Acupuncture Treatment for Insomnia in Postmenopausal Women

Clinical Efficacy Evaluation and Mechanism Research on Acupuncture Treatment for Insomnia in Postmenopausal Women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002003
Enrollment
Unknown
Registered
2025-10-22
Start date
2024-11-25
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopausal insomnia

Interventions

real acpuncture group:real acupunture treatment

Sponsors

Sichuan Jinxin Sinan Women's and Children's Hospital(Bisheng Branch)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Female aged 45–65 years right-handed; (2) Meeting the diagnostic criteria for the late postmenopausal stage per STRAW+10 and for chronic insomnia per ICSD-3; (3) Pittsburgh Sleep Quality Index (PSQI) score >7; (4) No medication use for at least 2 weeks prior to study entry; (5) Voluntary participation in the study with signed informed consent.

Exclusion criteria

Exclusion criteria: 1) Bilateral oophorectomy ovarian organic diseases premature ovarian failure polycystic ovary syndrome and hypothalamic amenorrhea patients;2) Patients with systemic diseases such as hypertension diabetes coronary heart disease and obesity (BMI = 28);3) Patients with severe life-threatening primary diseases such as cardiovascular hepatic renal and hematologic disorders;4) Patients with impaired consciousness who cannot express subjective discomfort symptoms;5) Personal or first-degree relatives with a history of psychiatric disorders or organic neurological diseases;6) Patients with insomnia caused by alcohol abuse and/or substance abuse (including sleeping pills);7) Patients with severe depression or anxiety symptoms;8) Patients with severe headaches migraines a history of head trauma or previous surgeries;9) Patients who have received estrogen serotonin reuptake inhibitors or other alternative therapies within 4 weeks before enrollment;10) History of anticoagulant use or routine use of sedatives or anxiolytics;11) Pregnancy planned pregnancy or breastfeeding;12) Patients with claustrophobia implanted metallic devices metal braces or other contraindications for MRI scanning.

Design outcomes

Primary

MeasureTime frame
insomnia assessment;

Secondary

MeasureTime frame
Clinical evaluation of postmenopausal relevance;Neuropsychological test;Neuroimaging test;Blood test;gut test;

Countries

China

Contacts

Public ContactWei Wei

Sichuan Jinxin Xinnan Women and Children's Hospital(Bisheng Branch)

1154491648@qq.com18408270924

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026